Article

Bladder Cancer Matters Podcast: Should Bladder Cancer Patients Work with an Oncology Social Worker?

The Bladder Cancer Advocacy Network's new podcast by, for, and about the bladder cancer community, "Bladder Cancer Matters," has a new episode available.

The Bladder Cancer Advocacy Network's new podcast by, for, and about the bladder cancer community, "Bladder Cancer Matters," has a new episode available.

In Episode 2 Part 1, host Rick Bangs chats with Dr. Heather Honoré Goltz. Rick and Heather discuss:

What oncology social work is and how it is different than other types of social work

How an oncology social worker can be helpful on a bladder cancer journey

Dr. Goltz is an Associate Professor of Social Work at the University of Houston-Downtown and a Research Investigator at the Michael E. DeBakey VA Medical Center. She is also the Chair of the Association of Oncology Social Workers Education Committee.

In case you missed it, you can catch Episode 1, Rick's interview with Dr. Ashish Kamat, "What's Up with Bladder Cancer and BCG?"

You can also listen and subscribe to this podcast through Apple Podcasts, Google Podcasts, Amazon Music Podcasts and more. If you subscribe through your favorite service, you'll be the first to know when a new episode is available.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of man.
Understanding Unique Treatment Options Across Bladder Cancer Care
Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment plan.
A Personalized Approach to Bladder Preservation in Urologic Cancers
Image of doctor.
Patient and Disease-Related Factors Influence Outcomes in Urothelial Cancer
Image of man.
Understanding the FDA Imfinzi Combo Approval for Bladder Cancer Care
Image of man with black hair.
Bavencio Maintains Bladder Cancer Benefit in Patients with Diabetes
Image of man.
Dr. Grivas Highlights Three Practice-Changing Trials in Bladder Cancer
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Better Understanding Genetic Mutations Influence in Cancer Care
Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium.
An Expert Highlights His Key Takeaways From The 2025 ASCO GU Symposium
Image of man with black hair.
Personalized Medicine Makes Strides Across the GU Oncology Treatment Space
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
An Expert Breaks Down the Effect of Diabetes on Urothelial Cancer Treatment
Related Content
Image of bladder.
May 15th 2025

Bladder Cancer Awareness Month Highlights the Importance of Early Detection

Ryan Scott
Dr. Daniel P. Petrylak sits down with CURE during Bladder Cancer Awareness Month to discuss key topics for patients with the disease.
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
January 30th 2024

Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

Alex Biese Brielle Benyon
Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
Illustration of bladder.
May 13th 2025

Custom-Made Vaccine Combo Proves Effective in Bladder Cancer

Ryan Scott
Treatment with a custom-made vaccine combination was found to be safe and feasible for patients with bladder cancer, eliciting a strong immune response.
cancer horizons podcast logo
December 20th 2023

FDA Approves 3 Treatments, Cancer Vaccine Shows Promise

Alex Biese Brielle Benyon
The Food and Drug Administration recently approved treatment for some patients with neuroblastoma, kidney cancer and bladder cancer. Elsewhere, a cancer vaccine made headlines for the treatment of patients with melanoma.
Image of bladder.
April 30th 2025

Aidixi Plus Bacillus Calmette-Guérin Effective in Bladder Cancer

Jason M Broderick
Aidixi plus BCG showed strong early efficacy and manageable safety in patients with high-risk, HER2-expressing non–muscle-invasive bladder cancer.
Illustration of bladder.
April 29th 2025

TAR-200 Shows High Response Rates in Bladder Cancer Subset

Kyle Doherty
TAR-200 showed high complete response rates in BCG-unresponsive, high-risk non-muscle invasive bladder cancer with CIS in the phase 2b SunRISe-1 study.